Cited by 182Antibiotic Resistance in BacteriaPharmaceutical and Antibiotic Environmental ImpactsBacterial Genetics and Biotechnology

Antidepressant fluoxetine induces multiple antibiotics resistance in Escherichia coli via ROS-mediated mutagenesis

Jin, Min, Lu, Ji, Chen, Zhaoyu, Nguyen, Son Hoang, Mao, Likai, Li, Junwen, Yuan, Zhiguo, Guo, Jianhua·2018·Environment International

Abstract

Background Antibiotic resistance poses a great threat to global public health. Overuse of antibiotics is generally considered as the major factor contributing to it. However, little is known about whether non-antibiotic drugs could play potential roles in the emergence of antibiotic resistance. Objective We aimed to investigate whether antidepressant fluoxetine induces multiple antibiotic resistances and reveal underlying mechanisms. Methodology Escherichia coli K12 was exposed to different concentrations of fluoxetine (0, 0.5, 5, 50 and 100 mg/L) and the resistant strains were isolated by plating on antibiotic containing plates. Resistant strains were randomly selected to determine the increase of minimum inhibition concentration (MIC) of multiple antibiotics. Genome-wide DNA sequencing was performed on cells cultured in lysogeny broth (LB) without any fluoxetine or antibiotics exposure. RNA sequencing and proteomic profiling of isolated mutants grown in LB with 100 mg/L fluoxetine were analyzed to reveal the underlying mechanisms. Results Exposure of Escherichia coli to fluoxetine at 5-100 mg/L after repeated subculture in LB for 30 days promoted its mutation frequency resulting in increased resistance against the antibiotics chloramphenicol, amoxicillin and tetracycline. This increase was up to 5.0 × 10 7 fold in a dose-time pattern. Isolated mutants with resistance to one of these antibiotics also exhibited multiple resistances against fluoroquinolone, aminoglycoside, β-l…

Integrity signals

Registry

Crossref · 10.1016/j.envint.2018.07.046

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • SSRIs including sertraline, paroxetine and fluoxetine have antimicrobial activity against gram-positive bacteria such as Staphylococcus and Enterococcus.

    “The antidepressant SSRIs (selective-serotonin reuptake inhibitors), including sertraline, paroxetine and fluoxetine (Jin et al., 2018), have antimicrobial activity against gram-positive bacteria such as Staphylococcus and Enterococcus (Ayaz et al., 2015;Coban et al., 2009).”

    From The Microbiota-Gut-Brain Axis (2019) · cites this paper as Jin et al., 2018

Cited by

Sorted by citations

Authors
Jin, M., Lu, J., Chen, Z., Nguyen, S. H., Mao, L., Li, J., Yuan, Z., & Guo, J.
Affiliations
The University of Queensland (AU)
Corresponding author
Guo, Jianhua
Venue
Environment International
Publisher
Elsevier BV
Published
2018-11
Volume
120
Pages
421-430
ISSN
0160-4120 (ISSN-L)
OpenAlex
W2885571787
Cited by
182
References
0
Citations by year
2026: 19 · 2025: 27 · 2024: 25 · 2023: 25 · 2022: 32 · 2021: 19 · 2020: 16 · 2019: 17 · 2018: 2
FWCI
4.95
Type
journal article
Language
en
Open access
closed
Locations
  • Environment International (publishedVersion)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
  • Australian Research Council (FT170100196)
  • UQ Foundation Research Excellence Awards
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Medicine › Antibiotic Resistance in Bacteria
  • Physical Sciences › Environmental Science › Pollution › Pharmaceutical and Antibiotic Environmental Impacts
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
Keywords
fluoxetine, antidepressants, antibiotic resistance, Escherichia coli, reactive oxygen species, efflux pumps, AcrAB-TolC, transcription factors, MarR, Rob, SdiA, C-reactive protein, multidrug resistance, off-target effects
MeSH terms
Anti-Bacterial Agents, Antidepressive Agents, Escherichia coli, Fluoxetine, Microbial Sensitivity Tests, Mutagenesis, Reactive Oxygen Species, Drug Resistance, Multiple, Bacterial, Membrane Transport Proteins, Escherichia coli Proteins, Proteomics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review